Business
Quantumzyme Announces Board Approval for Strategic Name Change to Quantum Genesis AI
SAN DIEGO, CA - December 1, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a pioneering biotransformation company revolutionizing pharmaceutical manufacturing through sustainable enzyme-based solutions, today announced that its Board of Directo...
About this update from Genesis Ai Corp
[{"type":"image","caption":"","headline":"Quantum Genesis AI Corp. Issues Statement Regarding OTC Markets Caveat Emptor Designation","size":{"original":{"width":140,"height":24,"url":"https://media.zenfs.com/en/newsmediawire_165/8773b4fd14e5c7599be5338e780c2b8f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Y0S9avEln5ZLy.1TqsNK.g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTM2O2NmPXdlYnA-/https://media.zenfs.com/en/newsmediawire_165/8773b4fd14e5c7599be5338e780c2b8f","width":140,"height":24}}},{"type":"text","content":"SAN DIEGO, CA - December 1, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a pioneering biotransformation company revolutionizing pharmaceutical manufacturing through sustainable enzyme-based solutions, today announced that its Board of Directors has approved a proposed corporate name change to Quantum Genesis AI Corp. The Company will now submit the required notice to the Financial Industry Regulatory Authority (FINRA), which will include a request to update its ticker symbol. The proposed change will take effect only following FINRA approval.","length":556,"tagName":"p"},{"type":"text","content":"The proposed rebranding reflects the Company's strategic intent to align its identity more closely with its expanding integration of artificial intelligence into its enzyme engineering initiatives. This prospective evolution of the corporate name is intended to signal the Company's forward-looking approach as it continues to develop technologies designed to support environmentally conscious pharmaceutical production.","length":428,"tagName":"p"},{"type":"text","content":""While the name change remains subject to regulatory approval, the proposed identity of Quantum Genesis AI represents the direction in which our research and development efforts are heading," said Naveen Kulkarni, Chief Executive Officer of Quantumzyme Corp. "This prospective evolution aligns with our continued work toward combining intelligence-driven computational tools with sustainable chemistry to support our long-term strategy."","length":457,"tagName":"p"},{"type":"text","content":"The Company's proprietary technology framework, pending the proposed name change and future enhancements, integrates quantum mechanics, molecular modeling, machine learning, and computational design principles. These tools are intended to support the development...